ACA
JAZZ icon

Atlas Capital Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Atlas Capital Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
4,983
-91
-2% -$19.9K 0.13% 135
2026
Q1 		$959K Buy
5,074
+1,967
+63% +$344K 0.11% 157
2025
Q4 		$528K Buy
+3,107
New +$476K 0.06% 247
2025
Q2 		$32.4K Sell
305
-4,309
-93% -$468K ﹤0.01% 672
2025
Q1 		$573K Buy
4,614
+4,302
+1,379% +$561K 0.07% 228
2024
Q4 		$38.4K Buy
+312
New +$36.8K ﹤0.01% 650

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Atlas Capital Advisors's JAZZ Position: Q2 2026 in Review

Atlas Capital Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.8% in Q2 2026, selling an estimated $19.9K and leaving 4,983 shares worth $1.2M. The position accounts for 0.13% of the portfolio, ranked #135.

Atlas Capital Advisors first reported a position in JAZZ in Q4 2024 and has held it in 6 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Atlas Capital Advisors held 4,983 shares of Jazz Pharmaceuticals worth $1.2M as of Q2 2026.
  • Atlas Capital Advisors sold 91 Jazz Pharmaceuticals shares in Q2 2026, an estimated $19.9K.
  • Jazz Pharmaceuticals made up 0.13% of Atlas Capital Advisors's portfolio in Q2 2026, its #135 holding.
  • Atlas Capital Advisors first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.